Skip to main content
. 2024 Jun 6;16(6):e61780. doi: 10.7759/cureus.61780

Table 2. Vaccine status of MSS and dMMR groups.

MSS, microsatellite stable; dMMR, deficient mismatch repair

  MSS (n=38)  dMMR (n=38) p-Value
BNT162b2 (n, %)
Yes  24 (63.2)  33 (86.8)  0.01
No 14 (36.8) 5 (13.2)
BNT162b2 dose (n, %)
1 dose  6 (25)  6 (18.1)   
2 doses  13 (54.1)  19 (57.6) 
3 doses  5 (20.9)  6 (18.1) 
4 doses 0 2 (6.2)
CoronaVac (Sinovac) (n, %)
Yes 28 (73.7)  23 (60.1)  0.32
No 10 (26.3) 15 (39.9)
CoronaVac dose (n, %)
2 doses 19 (67.9) 19 (82.6)   
3 doses 9 (32.1) 4 (17.4)